Otolaryngology Doctors in Mattoon, IL Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Lori Cudone, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr Ste 401, Mattoon, IL 61938 Phone: 217-258-2409    Fax: 217-258-2323

Michael Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr Ste 401, Mattoon, IL 61938 Phone: 217-258-2409    Fax: 217-258-2323

Dr. Sandra Lynn Ettema, M.D., PH.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr Ste 401, Mattoon, IL 61938 Phone: 217-258-2409

Dr. Harry Robert Borovik, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1000 Health Center Dr Ste 401, Mattoon, IL 61938 Phone: 217-258-2409    Fax: 217-258-2323

Charly Nguyen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr Ste 401, Mattoon, IL 61938 Phone: 217-258-2409    Fax: 217-258-2323

News Archive

Corticosteroid and antiviral agent combination proves to be beneficial for treating Bell Palsy

Among patients with Bell Palsy, a facial paralysis with unknown cause, treatment with corticosteroids is associated with a reduced risk of an unsatisfactory recovery, and treatment with a combination of corticosteroids and antiviral agents may be associated with additional benefit, according to a systematic review and meta-analysis of previously published studies, reported in the September 2 issue of JAMA.

KalVista raises £8 million in series A round of funding

KalVista Pharmaceuticals, a new ophthalmology company with a focus on diabetic macular edema (DME), has raised £8 million in a series A round from leading life sciences investors Novo A/S and SV Life Sciences.

Study finds disparities in male, female patients for heart disease treatment at U.S. hospitals

A study released today by HealthGrades, the nation's leading, independent source of physician information and hospital quality ratings, found notable disparities in the treatment and outcomes of male and female patients at U.S. hospitals.

High doses of 4-MEI in carbonated beverages may result in higher incidence of leukemia, says study

Last week, Consumer Reports released a study on the levels of a caramel coloring agent known as 4-methylimidazole (4-MEI) in many popular, carbonated beverages.

Study: Screening women aged 40-49 reduces breast cancer mortality

Breast screening women aged 40-49 reduces breast cancer mortality, with minimal increased overdiagnosis, according to a study led by Queen Mary University of London that looked at data from 160,000 women.

Read more Medical News

› Verified 3 days ago